The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Inhibitors of Alphavirus Entry and Replication Identified with a Stable Chikungunya Replicon Cell Line and Virus-Based Assays
Open accessAbstract
Chikungunya virus (CHIKV), an alphavirus, has recently caused epidemic outbreaks and is therefore considered a re-emerging pathogen for which no effective treatment is available. In this study, a CHIKV replicon containing the virus replicase proteins together with puromycin acetyltransferase, EGFP and Renilla luciferase marker genes was constructed. The replicon was transfected into BHK cells to yield a stable cell line. A non-cytopathic phenotype was achieved by a Pro718 to Gly substitution and a five amino acid insertion within non-structural protein 2 (nsP2), obtained through selection for stable growth. Characterization of the replicon cell line by Northern blotting analysis revealed reduced levels of viral RNA synthesis. The CHIKV replicon cell line was validated for antiviral screening in 96-well format and used for a focused screen of 356 compounds (natural compounds and clinically approved drugs). The 5,7-dihydroxyflavones apigenin, chrysin, naringenin and silybin were found to suppress activities of EGFP and Rluc marker genes expressed by the CHIKV replicon. In a concomitant screen against Semliki Forest virus (SFV), their anti-alphaviral activity was confirmed and several additional inhibitors of SFV with IC₅₀ values between 0.4 and 24 µM were identified. Chlorpromazine and five other compounds with a 10H-phenothiazinyl structure were shown to inhibit SFV entry using a novel entry assay based on a temperature-sensitive SFV mutant. These compounds also reduced SFV and Sindbis virus-induced cytopathic effect and inhibited SFV virion production in virus yield experiments. Finally, antiviral effects of selected compounds were confirmed using infectious CHIKV. In summary, the presented approach for discovering alphaviral inhibitors enabled us to identify potential lead structures for the development of alphavirus entry and replication phase inhibitors as well as demonstrated the usefulness of CHIKV replicon and SFV as biosafe surrogate models for anti-CHIKV screening.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The alphaviruses: gene expression, replication, and evolution.
Strauss, J. H., & Strauss, E. G. (1994) · Microbiological Reviews · doi:10.1128/mmbr.58.3.491-562.1994 · Cited by 2,221
Present and future arboviral threats
Weaver, S. C., & Reisen, W. K. (2010) · Antiviral Research · doi:10.1016/j.antiviral.2009.10.008 · Cited by 1,566
Infection with chikungunya virus in Italy: an outbreak in a temperate region
Rezza, G., Nicoletti, L., Angelini, R., Romi, R., Finarelli, A., Panning, M., Cordioli, P., Fortuna, C., Boros, S., Magurano, F., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61779-6 · Cited by 1,527
Effects of chloroquine on viral infections: an old drug against today's diseases
Savarino, A., Boelaert, J. R., Cassone, A., Majori, G., & Cauda, R. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00806-5 · Cited by 1,268
Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation.
Wang, L. H., Rothberg, K. G., & Anderson, R. G. (1993) · The Journal of cell biology · doi:10.1083/jcb.123.5.1107 · Cited by 1,177
The Global Emergence/Resurgence of Arboviral Diseases As Public Health Problems
Gubler, D. J. (2002) · Archives of Medical Research · doi:10.1016/s0188-4409(02)00378-8 · Cited by 1,135
Chikungunya, an epidemic arbovirosis
Pialoux, G., Gaüzère, B.-A., Jauréguiberry, S., & Strobel, M. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70107-x · Cited by 1,129
The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity
Crouch, S. P. M., Kozlowski, R., Slater, K. J., & Fletcher, J. (1993) · Journal of Immunological Methods · doi:10.1016/0022-1759(93)90011-u · Cited by 926
Changing patterns of chikungunya virus: re-emergence of a zoonotic arbovirus
Powers, A. M., & Logue, C. H. (2007) · Journal of General Virology · doi:10.1099/vir.0.82858-0 · Cited by 822
Novel antiviral agents: a medicinal plant perspective
Jassim, S. A. A., & Naji, M. A. (2003) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.2003.02026.x · Cited by 670
Couderc, T., Chrétien, F., Schilte, C., Disson, O., Brigitte, M., Guivel-Benhassine, F., Touret, Y., Barau, G., Cayet, N., Schuffenecker, I., et al. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.0040029 · Cited by 620
Hepatitis C Virus Entry Depends on Clathrin-Mediated Endocytosis
Blanchard, E., Belouzard, S., Goueslain, L., Wakita, T., Dubuisson, J., Wychowski, C., & Rouillé, Y. (2006) · Journal of Virology · doi:10.1128/jvi.00024-06 · Cited by 599
Characterization of Reemerging Chikungunya Virus
Sourisseau, M., Schilte, C., Casartelli, N., Trouillet, C., Guivel-Benhassine, F., Rudnicka, D., Sol-Foulon, N., Roux, K. L., Prevost, M.-C., Fsihi, H., et al. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030089 · Cited by 509
Rice, C. M., Levis, R., Strauss, J. H., & Huang, H. V. (1987) · Journal of Virology · doi:10.1128/jvi.61.12.3809-3819.1987 · Cited by 474
Liljeström, P., Lusa, S., Huylebroeck, D., & Garoff, H. (1991) · Journal of Virology · doi:10.1128/jvi.65.8.4107-4113.1991 · Cited by 452
Evolutionary Relationships and Systematics of the Alphaviruses
Powers, A. M., Brault, A. C., Shirako, Y., Strauss, E. G., Kang, W., Strauss, J. H., & Weaver, S. C. (2001) · Journal of Virology · doi:10.1128/jvi.75.21.10118-10131.2001 · Cited by 422
Sissoko, D., Malvy, D., Ezzedine, K., Renault, P., Moscetti, F., Ledrans, M., & Pierre, V. (2009) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0000389 · Cited by 419
Human Muscle Satellite Cells as Targets of Chikungunya Virus Infection
Ozden, S., Huerre, M., Rivière, J., Coffey, L. L., Afonso, P. V., Mouly, V., Monredon, J. D., Roger, J.-C., Amrani, M. E., Yvin, J.-L., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000527 · Cited by 338
Fros, J. J., Liu, W. J., Prow, N. A., Geertsema, C., Ligtenberg, M., Vanlandingham, D. L., Schnettler, E., Vlak, J. M., Suhrbier, A., Khromykh, A. A., et al. (2010) · Journal of Virology · doi:10.1128/jvi.00949-10 · Cited by 284
Briolant, S., Garin, D., Scaramozzino, N., Jouan, A., & Crance, J. M. (2004) · Antiviral Research · doi:10.1016/j.antiviral.2003.09.005 · Cited by 252
Inhibition of Semliki Forest Virus Penetration by Lysosomotropic Weak Bases
Helenius, A., Marsh, M., & White, J. (1982) · Journal of General Virology · doi:10.1099/0022-1317-58-1-47 · Cited by 248
On Chikungunya Acute Infection and Chloroquine Treatment
Lamballerie, X. D., Boisson, V., Reynier, J.-C., Enault, S., Charrel, R. N., Flahault, A., Roques, P., & Grand, R. L. (2008) · Vector-Borne and Zoonotic Diseases · doi:10.1089/vbz.2008.0049 · Cited by 245
Mycophenolic Acid Inhibits Dengue Virus Infection by Preventing Replication of Viral RNA
Diamond, M. S., Zachariah, M., & Harris, E. (2002) · Virology · doi:10.1006/viro.2002.1685 · Cited by 236
Neurologic Manifestations of Pediatric Chikungunya Infection
Robin, S., Ramful, D., Le Seach, F., Jaffar-Bandjee, M.-C., Rigou, G., & Alessandri, J.-L. (2008) · Journal of Child Neurology · doi:10.1177/0883073808314151 · Cited by 234
Noncytopathic Sindbis virus RNA vectors for heterologous gene expression
Agapov, E. V., Frolov, I., Lindenbach, B. D., Prágai, B. M., Schlesinger, S., & Rice, C. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.12989 · Cited by 214
Infectious Clones of Chikungunya Virus (La Réunion Isolate) for Vector Competence Studies
Tsetsarkin, K., Higgs, S., McGee, C. E., Lamballerie, X. D., Charrel, R. N., & Vanlandingham, D. L. (2006) · Vector-Borne and Zoonotic Diseases · doi:10.1089/vbz.2006.6.325 · Cited by 209
Chikungunya fever: CNS infection and pathologies of a re-emerging arbovirus
Das, T., Jaffar-Bandjee, M. C., Hoarau, J. J., Krejbich Trotot, P., Denizot, M., Lee-Pat-Yuen, G., Sahoo, R., Guiraud, P., Ramful, D., & Robin, S. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.12.006 · Cited by 206
Spuul, P., Balistreri, G., Kääriäinen, L., & Ahola, T. (2010) · Journal of Virology · doi:10.1128/jvi.00477-10 · Cited by 195
Self-citationSindbis Virus Nonstructural Protein nsP2 Is Cytotoxic and Inhibits Cellular Transcription
Garmashova, N., Gorchakov, R., Frolova, E., & Frolov, I. (2006) · Journal of Virology · doi:10.1128/jvi.02739-05 · Cited by 194
Selection of RNA Replicons Capable of Persistent Noncytopathic Replication in Mammalian Cells
Frolov, I., Agapov, E., Hoffman, T. A., Prágai, B. M., Lippa, M., Schlesinger, S., & Rice, C. M. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.3854-3865.1999 · Cited by 186
Lidbury, B. A., Rulli, N. E., Suhrbier, A., Smith, P. N., McColl, S. R., Cunningham, A. L., Tarkowski, A., van Rooijen, N., Fraser, R. J., & Mahalingam, S. (2008) · The Journal of Infectious Diseases · doi:10.1086/587841 · Cited by 152
Frolov, I. V., & Schlesinger, S. (1994) · Journal of Virology · doi:10.1128/jvi.68.3.1721-1727.1994 · Cited by 145
Gould, E. A., Coutard, B., Malet, H., Morin, B. M., Jamal, S., Weaver, S. C., Gorbalenya, A. E., Moureau, G., Baronti, C., Delogu, I., et al. (2009) · Antiviral Research · doi:10.1016/j.antiviral.2009.07.007 · Cited by 134
Perri, S., Driver, D. A., Gardner, J. P., Sherrill, S., Belli, B., Dubensky, T. W., & Polo, J. M. (2000) · Journal of Virology · doi:10.1128/jvi.74.20.9802-9807.2000 · Cited by 130
Dryga, S. A., Dryga, O., & Schlesinger, S. (1997) · Virology · doi:10.1006/viro.1996.8364 · Cited by 129
Nuclear and nucleolar targeting signals of semliki forest virus nonstructural protein nsP2
Rikkonen, M., Peränen, J., & Kääriäinen, L. (1992) · Virology · doi:10.1016/0042-6822(92)90570-f · Cited by 125
Immuno-biology of Chikungunya and implications for disease intervention
Kam, Y., Ong, E. K. S., Rénia, L., Tong, J. C., & Ng, L. F. P. (2009) · Microbes and Infection · doi:10.1016/j.micinf.2009.09.003 · Cited by 100
Role for nsP2 Proteins in the Cessation of Alphavirus Minus-Strand Synthesis by Host Cells
Sawicki, D. L., Perri, S., Polo, J. M., & Sawicki, S. G. (2005) · Journal of Virology · doi:10.1128/jvi.80.1.360-371.2006 · Cited by 77
Tamm, K., Merits, A., & Sarand, I. (2008) · Journal of General Virology · doi:10.1099/vir.0.83320-0 · Cited by 74
Self-citationFrolov, I. V., Garmashova, N., Atasheva, S., & Frolova, E. I. (2009) · Journal of Virology · doi:10.1128/jvi.00850-09 · Cited by 60
Casales, E., Rodríguez-Madoz, J. R., Ruiz-Guillen, M., Razquin, N., Cuevas, Y., Prìeto, J., & Smerdou, C. (2008) · Virology · doi:10.1016/j.virol.2008.03.016 · Cited by 28
Cited by
de Wilde, A. H., Jochmans, D., Posthuma, C. C., Zevenhoven-Dobbe, J. C., van Nieuwkoop, S., Bestebroer, T. M., van den Hoogen, B. G., Neyts, J., & Snijder, E. J. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03011-14 · Cited by 736
Flavonoids: Promising Natural Compounds against Viral Infections
Zakaryan, H., Arabyan, E., Oo, A., & Zandi, K. (2017) · Archives of Virology · doi:10.1007/s00705-017-3417-y · Cited by 534
Recent discovery and development of inhibitors targeting coronaviruses
Pillaiyar, T., Meenakshisundaram, S., & Manickam, M. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.01.015 · Cited by 361
Pillaiyar, T., Meenakshisundaram, S., Manickam, M., & Sankaranarayanan, M. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112275 · Cited by 140
Repurposing chlorpromazine to treat COVID-19: the reCoVery study
Plaze, M., Attali, D., Petit, A.-C., Blatzer, M., Simon-Loriere, E., Vinckier, F., Cachia, A., Chrétien, F., & Gaillard, R. (2020) · L'Encéphale · doi:10.1016/j.encep.2020.05.006 · Cited by 101
Metadata
- Authors
- Pohjala, L., Utt, A., Varjak, M., Lulla, A., Merits, A., Ahola, T., & Tammela, P.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-12-19
- Volume
- 6
- Issue
- 12
- Pages
- e28923
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2171094736
- Cited by
- 270
- References
- 41
- FWCI
- 10.58
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.